BioSpace News Archive

BIORCHESTRA will attend the JPM@BIO with the goal of pursuing diverse transactions and research collaborations in San Francisco during the 41st Annual J.P. Morgan Healthcare conference.

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today provided an update on the Company’s four pillars and outlined its near-term strategic priorities.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Novan, Inc. (Nasdaq: NOVN) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking marketing approval for berdazimer gel, 10.3% (SB206) for the topical treatment of molluscum contagiosum (molluscum).

Neuralace Medical, Inc. is announcing the upcoming presentation by the VA Augusta of its pilot study focused on assessing the impact of Axon Magnetic Peripheral Nerve Stimulation (mPNS).

Celularity Inc. announced today that its re-analysis of long term follow-up data from three legacy Phase 1, Phase 1b/2a and Phase 1b studies of its legacy placental-derived mesenchymal-like adherent stromal cell (MLASC) therapy in moderate-to-severe Crohn’s disease patients showed clinically meaningful and durable benefit for up to two years in the limited number of patients studied and warrants further investigation.

Montrose Environmental Group, Inc. (“Montrose” or “the Company”) (NYSE: MEG) today announced the acquisition of Frontier Analytical Laboratories.

FSD Pharma Inc. announced today that senior executive management is attending the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023, in San Francisco, California.

Seegene Technologies, Inc. announced it will change names and begin doing business as Seegene USA, Inc. , effective Jan. 1, 2023.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 3, 2023 at 8:30 a.m. ET.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, January 12, 2023.